Research has shown that CRY1 is associated with components of metabolic syndrome, such as hypertension and triglyceride (25) levels, as well as obesity and insulin resistance (IR) (26, 27). Here, CRY1 is linked to obesity due to melanocortin 4 receptor deficiency.